| 3.915 0.105 (2.76%) | 05-22 15:02 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 10.29 | 1-year : | 14.01 |
| Resists | First : | 8.81 | Second : | 12 |
| Pivot price | 4.49  |
|||
| Supports | First : | 3.67 | Second : | 3.05 |
| MAs | MA(5) : | 4.13 |
MA(20) : | 4.75 |
| MA(100) : | 154.91 |
MA(250) : | 897.18 |
|
| MACD | MACD : | -5.5 |
Signal : | -7.5 |
| %K %D | K(14,3) : | 8.4 |
D(3) : | 7.2 |
| RSI | RSI(14): 29 |
|||
| 52-week | High : | 5445 | Low : | 3.29 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ STSS ] has closed above bottom band by 3.4%. Bollinger Bands are 99.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 66 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 4.1 - 4.14 | 4.14 - 4.16 |
| Low: | 3.61 - 3.64 | 3.64 - 3.66 |
| Close: | 3.76 - 3.82 | 3.82 - 3.85 |
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
Thu, 22 May 2025
Sharps Technology Regains Nasdaq Compliance - TipRanks
Thu, 22 May 2025
Sharps Technology (STSS) Reinstates Nasdaq Compliance - GuruFocus
Thu, 22 May 2025
Sharps Technology Regains Compliance with Nasdaq Minimum Bid Price Listing Rule - GlobeNewswire
Wed, 21 May 2025
Sharps Technology to Present at the Aegis Capital Corp. 2025 Virtual Conference on May 22nd - GlobeNewswire
Wed, 21 May 2025
Medical Device Innovator Sharps Technology to Unveil Latest Smart-Safety Syringe Developments at Aegis Conference - Stock Titan
Fri, 16 May 2025
Sharps Technology sets $20 million public offering price - MSN
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 0 (M) |
| Shares Float | 16 (M) |
| Held by Insiders | 53230 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 21 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -2 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -63 % |
| Return on Equity (ttm) | -187.3 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -4.15493e+006 |
| Qtrly Earnings Growth | 220 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -7 (M) |
| PE Ratio | -1.95 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 8.45 |
| Dividend | 0 |
| Forward Dividend | 11450 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|